* Says it will use up to $6 million, aiming to hold 43.1
percent stake in Response Biomedical Corp, which is
engaged in POCT business
The post BRIEF-Shanghai Runda Medical Technology to raise stake in Response Biomedical Corp to 43.1 pct appeared first on NASDAQ.